New immunomodulating drugs in autoimmune blistering diseases

Dermatologic Clinics

Volumn 19, Issue 4, 2001, Pages 637-648

  Korman, Neil J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISONE; STEROID; TETRACYCLINE;

AUTOIMMUNE DISEASE; BLISTER; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; DRUG INDUCED DISEASE; EPIDERMOLYSIS BULLOSA ACQUISITA; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; PEMPHIGOID; PRIORITY JOURNAL; PUVA; REVIEW; SKIN BIOPSY; STEROID THERAPY;

EID: 0034765275     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70305-3     Document Type: Article

References (110)

1. Azathioprine in the treatment of pemphigus vulgaris
2. Bullous pemphigoid: Clinical and immunologic follow-up after successful therapy
3. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia
4. Linear IgA bullous dermatosis: Successful treatment with colchicine
5. Generalized pruritus as the presenting feature of bullous pemphigoid
6. Dapsone as initial treatment in superficial pemphigus. Report of nine cases
7. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy
8. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: Experience in six patients
9. The treatment of bullous pemphigoid with tetracycline and niacinamide
10. Treatment of ocular cicatricial pemphigoid with intravenous gammaglobulin
11. Bullous pemphigoid treated with mycophenolate mofetil
12. Methotrexate and cyclosporine are of value in the treatment of adult linear IgA disease
13. Paraneoplastic pemphigus: A report of three cases including one long-term survivor
14. Epidermolysis bullosa acquisita
15. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline
16. Interferon alpha for linear IgA bullous dermatosis
17. Immune-mediated subepithelial blistering diseases of mucous membranes
18. Laminin-6 and laminin- 5 are recognized by autoantibodies in a subset of cicatricial pemphigoid
19. Linear IgA bullous dermatosis of adults
20. Treatment of epidermolysis bullosa acquisita with cyclosporine
21. Clearing of epidermolysis bullosa acquisita with cyclosporine
22. Colchicine for epidermolysis bullosa acquisita
23. Antiepiligrin cicatricial pemphigoid. A subepithehal bullous disorder
24. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid
25. Topical cyclosporine for oral bullous disorders
26. Sulfapyridine-A new agent for the treatment of ocular cicatricial pemphigoid
27. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris
28. Mycophenolate is effective in the treatment of pemphigus vulgaris
29. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris
30. Pulse intravenous cyclophosphamide therapy in pemphigus
31. Cicatricial pemphigoid
32. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study
33. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid
34. Antiepiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita
35. Epidermolysis bullosa acquisita: Clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer
36. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
37. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy
38. Controlled study of plasma exchange in pemphigus
39. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid
40. Clinical, histological, and immunological studies in 50 patients with bullous pemphigoid
41. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris
42. Lowdose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid
43. Pure ocular cicatricial pemphigoiod: A distinct immunopathologic subset of cicatricial pemphigoid
44. Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy
45. Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide
46. A clinicopathological study of mucosal involvement in linear IgA disease
47. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex
48. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita
49. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide
50. Pemphigus: An update
51. Paraneoplastic pemphigus
52. Pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus
53. Update on the use of azathioprine in the management of pemphigus and bullous pemphigoid
54. Immune-mediated subepithelial blistering diseases of the mucous membranes: Improving the detection of circulating auto-antibodies by the use of concentrated sera
55. Update on the use of cyclophosphamide in the management of pemphigus, bullouspemphigoid and cicatricial pemphigoid
56. Bullous pemphigoid: The latest in diagnosis, prognosis and therapy
57. Cyclophosphamide in the treatment of pemphigus vulugaris and bullous pemphigoid
58. High-dose intravenous immune globulin is also effective in linear IgA disease
59. Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits
60. Clearing of epidermolysis bullosa acquisita with cyclosporine
61. Cyclosporine consensus conference with emphasis on the treatment of psoriasis
62. Oral insertable prosthetic device as an aid in treating oral ulcers
63. Desmoglein 3-ELISA: A pemphigus vulgaris-specific diagnostic tool
64. Linear IgA disease
65. Pemphigus
66. Pemphigus and pemphigoid
67. Antiepiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
68. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy
69. The use of chlorambucil in the treatment of bullous pemphigoid
70. Oral pemphigoid: Subset of cicatricial pemphigoid?
71. Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine
72. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins
73. Bullous pemphigoid treated with leflunomide
74. Successful therapy for bullous pemphigoid with mycophenolate mofetil
75. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus
76. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide
77. Treatment of pemphigus with gold
78. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid
79. Linear IgA bullous dermatosis: Successful treatment with tetracycline and nicotinamide
80. Bullous and cicatricial pemphigoid
81. Bullous pemphigoid responding to sulfapyridine and the sulfones
82. Minimizing cicatricial pemphigoid orodynia with minocycline
83. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid
84. Pemphigus in remission. Value of direct immunofluorescence in management
85. Treatment of chronic bullous dermatosis of childhood with oral dicloxacillin
86. The new pemphigus variants
87. Treatment of cicatricial pemphigoid with dapsone
88. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris
89. Plasma exchange in bullous pemphigoid
90. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma
91. Serum levels of autoantibodies to BP 180 correlate with disease activity in patients with bullous pemphigoid
92. Immunoapheresis in paraneoplastic pemphigus
93. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease
94. High-dose methylprednisolone in the treatment of bullous pemphigoid
95. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in cicatricial pemphigoid
96. The role of genetic variation in thiopurine methyltransferase activity and the efficacy or side effects of azathioprine in dermatologic patients
97. The medical dermatology society
98. Treatment of bullous diseases with corticosteroid drugs and corticotrophin
99. Paraneoplastic pemphigus: A case with high titer of circulating anti-basement membrane zone antibodies
100. Effects of cyclosporin on bullous pemphigoid and pemphigus
101. An open clinical trial of sulphamethoxy-pyridazine in the treatment of mucous membrane memphigoid
102. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization
103. Cicatricial pemphigoid treated with intravenous immunoglobulin
104. Dapsone as first line therapy for bullous pemphigoid
105. Cicatrizing conjunctivitis as a predominant manifestation of linear IgA bullous dermatosis
106. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids
107. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults
108. Epidermolysis bullosa acquisita
109. A highly sensitive ELISA assay for the detection of circulating anti-BP 180 autoantibodies in patients with bullous pemphigoid
110. The 97 KD linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 KD bullous pemphigoid antigen